Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

extramedullary soft tissue plasmacytoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

extramedullary soft tissue plasmacytoma

MONDO:0015043

Overview

TreatmentsNo approved treatments · 1 in pipeline

ResearchLimited published research (3 articles)

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for extramedullary soft tissue plasmacytoma. An additional 1 compound holds orphan drug designation.

Orphan Drug Designations

While no drugs are FDA-approved specifically for extramedullary soft tissue plasmacytoma, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.

The following drugs have received orphan drug designation from the FDA for extramedullary soft tissue plasmacytoma. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Brand Name	Generic Name	Sponsor

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for extramedullary soft tissue plasmacytoma.

3 publications have been identified in PubMed for extramedullary soft tissue plasmacytoma. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (33%), and Clinical Trial Publication (33%).

Recent Publications

Testa U (2025). [PMID: 39830797](https://pubmed.ncbi.nlm.nih.gov/39830797/). *Mediterranean journal of hematology and infectious diseases*. [Review / Meta-Analysis]
Alexander VS (2024). [PMID: 38784303](https://pubmed.ncbi.nlm.nih.gov/38784303/). *Cureus*. [Case Report / Case Series]
Zolnowski D (2024). [PMID: 39470843](https://pubmed.ncbi.nlm.nih.gov/39470843/). *Journal of cancer research and clinical oncology*. [Clinical Trial Publication]

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:100022

GARD

Genetic and Rare Diseases Info Center

GARD:19740

Questions for Your Care Team

→What is the current development status of ifosfamide, and when might it become available?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

extramedullary soft tissue plasmacytoma

Overview

Treatment

Orphan Drug Designations

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials